ClinicalTrials.Veeva

Menu

Treatment of Negative Symptoms of Schizophrenia by rTMS (SN RENAT)

C

Centre hospitalier de Ville-Evrard, France

Status

Enrolling

Conditions

Negative Symptoms in Schizophrenia
Schizophrenia

Treatments

Other: repetitive Transcranial Magnetic Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06595654
2021-A02710-40

Details and patient eligibility

About

The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).

Enrollment

124 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years of age
  • Patient diagnosed with schizophrenia according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013)
  • Stable drug treatment for at least 4 weeks
  • Presence or persistence of negative symptoms in the foreground:

Negative PANSS score ⩾21, positive PANSS score ⩽24

  • Patient (or legal representative) willing to participate in the study and having signed an informed consent
  • Patient fluent in the French language
  • Affiliation to a social security scheme

Exclusion criteria

  • Present a contraindication to TMS: intracranial foreign body, unstabilized epilepsy, cochlear implant, pace-maker
  • Presence of an unstabilized medical condition
  • Pregnant woman
  • Woman of childbearing potential and without effective contraception
  • Breastfeeding woman

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

124 participants in 4 patient groups

Method 1
Other group
Description:
One stimulation session per day for 20 working days, so 4 weeks (frequency of 10 Hz, 80% 100% of motor threshold). Each session lasts 20 min. The duration of the train is 4 s, an inter-train of 56s.
Treatment:
Other: repetitive Transcranial Magnetic Stimulation
Method 2
Other group
Description:
Two stimulations sessions per day, with 1 hour apart, for 20 working days, so 4 weeks (frequency of 20 Hz, 100% of motor threshold).Each session lasts 28 min. The duration of the train of 10 s, an inter-train of 80s The total number of pulses is 40000 in 20 trains or 2000 per day.
Treatment:
Other: repetitive Transcranial Magnetic Stimulation
Method 3
Other group
Description:
Two stimulations session per day for 10 working days, so 2 weeks. The protocol is delivered in bursts containing 3 pulses at 50 Hz repeated at 200 ms intervals for 2 s (i.e., 5 Hz). Stimulation intensity is set at 80% of the idle motor threshold intensity
Treatment:
Other: repetitive Transcranial Magnetic Stimulation
Method 4
Other group
Description:
Five to ten sessions per day, 50 minutes apart, with 90% SM for 10 working days, so 2 weeks. 1 of stimuli every 20 ms (50Hz) repeated 3 times, this train itself repeated every 200 ms (5 Hz) or 60 cycles of 10 blocks of 3 stimuli. The duration of the train is 2 seconds with an inter-train of 8 seconds. So there are 1800 stimuli per session
Treatment:
Other: repetitive Transcranial Magnetic Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Youcef Bencherif

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems